What is the immediate management of Acute Respiratory Distress Syndrome (ARDS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Management of Acute Respiratory Distress Syndrome (ARDS)

Initiate lung-protective mechanical ventilation immediately with low tidal volumes (4-8 ml/kg predicted body weight) and plateau pressures below 30 cmH2O, as this is the cornerstone intervention that reduces mortality in ARDS. 1, 2

Initial Assessment and Classification

  • Confirm ARDS diagnosis using Berlin criteria: acute onset within 1 week of known insult, bilateral opacities on chest imaging, PaO2/FiO2 ≤300 mmHg with minimum PEEP of 5 cmH2O, and respiratory failure not fully explained by cardiac failure or fluid overload 1

  • Classify severity immediately based on PaO2/FiO2 ratio while on PEEP ≥5 cmH2O: 1, 2

    • Mild: 200-300 mmHg
    • Moderate: 100-200 mmHg
    • Severe: <100 mmHg

Immediate Ventilatory Management

Lung-Protective Ventilation (All Patients):

  • Set tidal volume at 4-8 ml/kg predicted body weight (target 6 ml/kg) 1, 2
  • Maintain plateau pressure <30 cmH2O 1, 2
  • Target oxygen saturation 88-95% or PaO2 55-80 mmHg to avoid excessive FiO2 1

PEEP Strategy:

  • Apply higher PEEP (typically 10-15 cmH2O) in moderate to severe ARDS without prolonged recruitment maneuvers 1, 2
  • Titrate PEEP based on oxygenation, hemodynamic tolerance, and driving pressure (plateau pressure minus PEEP) 1
  • Avoid prolonged lung recruitment maneuvers (strong recommendation) as they increase mortality risk 1, 2

Immediate Adjunctive Therapies Based on Severity

For Severe ARDS (PaO2/FiO2 <150 mmHg or <100 mmHg):

  • Implement prone positioning immediately for at least 12-16 hours per day, as this significantly reduces mortality in severe ARDS 1, 2, 3
  • Initiate early neuromuscular blockade (cisatracurium preferred) for 48 hours in early severe ARDS 1, 2, 3
  • Start corticosteroids (conditional recommendation with moderate certainty) 1, 2

For Moderate ARDS (PaO2/FiO2 100-200 mmHg):

  • Consider prone positioning if oxygenation remains poor despite optimization 2
  • Consider corticosteroids 1, 2
  • Apply higher PEEP strategy 1, 2

Fluid Management

  • Implement conservative fluid strategy immediately after initial resuscitation to minimize pulmonary edema and reduce ventilator days 2, 4
  • Avoid fluid overload which worsens oxygenation and promotes right ventricular dysfunction 1, 5

Hemodynamic Monitoring

  • Monitor for acute cor pulmonale using echocardiography, as high airway pressures and hypoxemia increase right ventricular afterload 1
  • Ensure adequate preload without overdistension, as RV failure significantly worsens outcomes 1
  • Maintain mean arterial pressure adequate for organ perfusion while avoiding excessive vasopressor use 1

Escalation Pathway for Refractory Hypoxemia

If PaO2/FiO2 remains <80 mmHg despite above measures:

  • Verify prone positioning is optimized (>12 hours daily) 1, 2
  • Confirm neuromuscular blockade is adequate 1, 2
  • Consider inhaled pulmonary vasodilators (nitric oxide or epoprostenol) for temporary oxygenation improvement, though mortality benefit is unproven 1, 3
  • Initiate venovenous ECMO at an experienced center for selected patients with severe refractory ARDS who have failed conventional therapies 1, 2, 4

Critical Pitfalls to Avoid

  • Never use high tidal volumes (>8 ml/kg) or allow plateau pressures >30 cmH2O, as this causes ventilator-induced lung injury and increases mortality 1, 2
  • Do not delay prone positioning in severe ARDS—early implementation (within 24-48 hours) provides maximum benefit 2, 4
  • Avoid prolonged recruitment maneuvers (sustained inflations >30 seconds), as these increase mortality 1, 2
  • Do not use high-frequency oscillatory ventilation, as it increases mortality 3
  • Avoid excessive fluid administration after initial resuscitation, as positive fluid balance worsens outcomes 2, 4
  • Do not start corticosteroids >2 weeks after ARDS onset, as late initiation may be harmful 2

Monitoring and Weaning

  • Reduce sedation and assess for spontaneous breathing trials daily once gas exchange improves and FiO2 <0.5 with PEEP <10 cmH2O 1
  • Implement daily spontaneous breathing trials as the central weaning strategy 2
  • Consider tracheostomy if prolonged mechanical ventilation (>2 weeks) is anticipated 1

Special Considerations for ECMO

  • ECMO should only be performed at high-volume experienced centers due to technical complexity and resource requirements 1, 2
  • Patient selection criteria include: age <65 years, mechanical ventilation <7 days, absence of irreversible multiorgan failure, and severe hypoxemia (PaO2/FiO2 <80 mmHg) despite maximal conventional therapy 1, 4
  • ECMO provides modest mortality benefit (approximately 20% relative risk reduction) but requires careful patient selection 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Respiratory Distress Syndrome Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Acute Respiratory Distress Syndrome in Acute Pancreatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.